DarioHealth Corp (NASDAQ: DRIO) kicked off on Friday, up 30.50% from the previous trading day, before settling in for the closing price of $0.56. Over the past 52 weeks, DRIO has traded in a range of $0.50-$1.93.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 42.45% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 57.38%. With a float of $30.92 million, this company’s outstanding shares have now reached $38.39 million.
In an organization with 202 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 49.06%, operating margin of -551.71%, and the pretax margin is -65.27%.
DarioHealth Corp (DRIO) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of DarioHealth Corp is 25.62%, while institutional ownership is 18.84%. The most recent insider transaction that took place on Nov 12 ’24, was worth 4,546. In this transaction Chief Commercial Officer of this company bought 5,000 shares at a rate of $0.91, taking the stock ownership to the 55,000 shares. Before that another transaction happened on Sep 10 ’24, when Company’s Chief Commercial Officer bought 5,000 for $0.84, making the entire transaction worth $4,221. This insider now owns 45,000 shares in total.
DarioHealth Corp (DRIO) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 57.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 56.56% during the next five years compared to 41.84% growth over the previous five years of trading.
DarioHealth Corp (NASDAQ: DRIO) Trading Performance Indicators
Take a look at DarioHealth Corp’s (DRIO) current performance indicators. Last quarter, stock had a quick ratio of 2.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.19 in one year’s time.
Technical Analysis of DarioHealth Corp (DRIO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.39 million. That was inferior than the volume of 0.69 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 56.90%. Additionally, its Average True Range was 0.07.
During the past 100 days, DarioHealth Corp’s (DRIO) raw stochastic average was set at 21.40%, which indicates a significant decrease from 91.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 129.10% in the past 14 days, which was lower than the 160.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6535, while its 200-day Moving Average is $0.8567. However, in the short run, DarioHealth Corp’s stock first resistance to watch stands at $0.7881. Second resistance stands at $0.8505. The third major resistance level sits at $0.9546. If the price goes on to break the first support level at $0.6216, it is likely to go to the next support level at $0.5175. The third support level lies at $0.4551 if the price breaches the second support level.
DarioHealth Corp (NASDAQ: DRIO) Key Stats
The company with the Market Capitalisation of 30.16 million has total of 41,567K Shares Outstanding. Its annual sales at the moment are 27,040 K in contrast with the sum of -42,750 K annual income. Company’s last quarter sales were recorded 7,600 K and last quarter income was -9,630 K.
